John Johnson is Executive Chairman of Applied Therapeutics Inc.. Currently has a direct ownership of 500,000 shares of APLT, which is worth approximately $295,000. The most recent transaction as insider was on Dec 19, 2024, when has been sold 500,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 500K
n/a 3M change
n/a 12M change
Total Value Held $295,000

JOHN JOHNSON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 19 2024
BUY
Grant, award, or other acquisition
-
500,000 Added 50.0%
500,000 Common Stock

Also insider at

AXGN
Axogen, Inc. Healthcare
VSTM
Verastem, Inc. Healthcare
XERS
Xeris Biopharma Holdings, Inc. Healthcare
SBBP
Strongbridge Biopharma plc
JJ

John Johnson

Executive Chairman
Trevose, PA

Track Institutional and Insider Activities on APLT

Follow Applied Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLT shares.

Notify only if

Insider Trading

Get notified when an Applied Therapeutics Inc. insider buys or sells APLT shares.

Notify only if

News

Receive news related to Applied Therapeutics Inc.

Track Activities on APLT